| 会计年度 | 2023 | 2024 | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | --- | | 营业总收入(百万元) | 2427 | 2525 | 2780 | 3575 | 4375 | | 同比增长 | 23% | 4% | 10% | 29% | 22% | | 营业利润(百万元) | 401 | 266 | 162 | 261 | 333 | | 同比增长 | 43% | -34% | -39% | 60% | 28% | | 归母净利润(百万元) | 315 | 201 | 123 | 197 | 251 | | 同比增长 | 37% | -36% | -39% | 60% | 28% | | 每股收益(元) | 0.65 | 0.42 | 0.26 | 0.41 | 0.52 | | PE | 35.7 | 55.9 | 91.4 | 57.1 | 44.8 | | PB | 3.5 | 3.7 | 3.7 | 3.5 | 3.3 | 证券研究报告 | 公司点评报告 2026 年 03 月 01 日 金宏气体（6881 ...

报告期内，影响公司经营业绩的主要因素是：(1)公司为应对复杂多变的市场环境，积极开拓市场，销 量持续快速增长，但市场竞争加剧，导致部分产品的售价及综合毛利率均有一定程度的下降；(2)公司 前期逆势布局，项目投资逐步完工导致折旧费用增加；(3)资产处置收益较去年同期下降。综合上述原 因导致公司净利润同比有所下滑。 格隆汇2月27日丨金宏气体(688106.SH)发布2025年年度业绩快报，报告期内，公司营业总收入27.80亿 元，较上年同期增长10.09%；归属于上市公司股东的净利润1.23亿元，较上年同期下降39.08%。 ...

格隆汇2月27日丨华特气体(688268.SH)公布2025年度业绩快报，2025年度公司实现营业总收入14.19亿 元，同比上升1.72%，实现归属于母公司股东的净利润1.44亿元，同比下降22.17%，实现归属于母公司 股东的扣除非经常性损益的净利润1.31亿元，同比下降25.07%；报告期末，公司总资产35.95亿元，较 报告期初增长8.9%，归属于母公司股东的所有者权益20.25亿元，较报告期初增长3.86%。 ...

金宏气体公告，2025年度营业总收入27.8亿元，同比增长10.09%。净利润1.23亿元，同比下降39.08%。 报告期内，影响公司经营业绩的主要因素是：（1）公司为应对复杂多变的市场环境，积极开拓市场， 销量持续快速增长，但市场竞争加剧，导致部分产品的售价及综合毛利率均有一定程度的下降；（2） 公司前期逆势布局，项目投资逐步完工导致折旧费用增加；（3）资产处置收益较去年同期下降。综合 上述原因导致公司净利润同比有所下滑。 ...

格隆汇2月26日丨侨源股份(301286.SZ)在互动平台表示，公司作为西南地区核心气体供应商之一，产品 涵盖高纯氧气、高纯氮气、高纯氩气及特气产品等多种气体。公司部分气体产品已应用于航空航天领 域，并与川内多家核心军工 及 航天单位建立合作关系。 ...

证券日报网讯2月24日，和远气体（002971）在互动平台回答投资者提问时表示，截至2月13日公司的股 东人数是14086户。 ...

Core Viewpoint - The company is focusing on the production capacity of electronic specialty gases, particularly fluorine-based products, which are expected to enter customer validation and introduction by Q3 2026 [1] Group 1: Production and Development - The company's fluorine-based electronic specialty gas products have entered trial production and are primarily used in high-end manufacturing sectors such as semiconductors and chips [1] Group 2: Shareholder Information - As of January 31, 2026, the number of shareholders has decreased to 15,735, a reduction of 8.97% from January 20, marking the second consecutive decline [2] - During this period of concentrated shareholding, the stock price has increased by 2.16% [2] Group 3: Financial Performance - The company's revenue for the first three quarters of 2025 was 1.232 billion yuan, reflecting a year-on-year growth of 3.32% [3] - The net profit attributable to shareholders was 57.7037 million yuan, showing a slight decline of 1.86% year-on-year [3] - As of early January 2026, the company's price-to-earnings ratio (TTM) was 92.43 times, and the price-to-book ratio was 4.18 times, indicating a valuation level above the industry average [3] Group 4: Stock Performance - The stock price has experienced significant volatility, with a decline of 19.74% over the past 60 days, but an increase of 2.10% over the last 20 days [4] - The closing price on February 4 was 31.19 yuan, with a daily increase of 1.53% [4] - On February 3, there was a net outflow of 1.2451 million yuan in main capital [4] Group 5: Institutional Insights - As of mid-January 2026, only one institution has covered the stock in the last 90 days, giving it an "overweight" rating [5] - Huaxia Industry Prosperity Mixed Securities Investment Fund is among the top ten circulating shareholders [5]

Core Viewpoint - Qiaoyuan Co., Ltd. reported that as of January 30, 2026, the total number of shareholders is 7,972 [2] Company Information - The company has engaged with investors through an interactive platform to provide updates on shareholder numbers [2] - The total number of shareholders indicates a growing interest in the company, which may reflect its market performance and investor confidence [2]

Fundraising Overview - The company has been approved to publicly issue 12,108,340 shares at a price of RMB 15.48 per share, raising a total of RMB 1,874.371 million, with a net amount of RMB 1,759.511 million after deducting issuance costs of RMB 114.8604 million [1][2] - As of June 11, 2020, all raised funds have been received and verified by the accounting firm Rongcheng [1] Fund Management - The company has established a regulatory framework for managing the raised funds, ensuring compliance with relevant laws and regulations, including the "Regulations on the Supervision of Fundraising by Listed Companies" and the "Self-Regulatory Guidelines for Listed Companies on the Science and Technology Innovation Board" [1] - The company, its subsidiaries, and the sponsor, Dongwu Securities, have signed tripartite and quadripartite agreements with the commercial bank holding the raised funds to oversee the storage and usage of the funds [1] Account Closure - The special account for the raised funds related to the "Northern Integrated Circuit Phase II Electronic Bulk Gas Project" has been closed after using RMB 82.7389 million, with no remaining funds expected [2] - The company has completed the closure of the special account at CITIC Bank, and the corresponding regulatory agreement has been terminated [2]

Core Viewpoint - Qiaoyuan Co., Ltd. announced that its wholly-owned subsidiary, Qiaoyuan Gas (Meishan) Co., Ltd., has recently obtained a revised "Drug Production License" from the Sichuan Provincial Drug Administration, allowing for changes in the production scope of the license [2] Group 1 - The company has received regulatory approval for its subsidiary's drug production license, indicating a significant step in its operational capabilities [2] - The change in the production scope may enhance the company's product offerings and market competitiveness in the pharmaceutical sector [2]